Presence of hyperalgesia predicts analgesic efficacy of topically applied capsaicin 8% in patients with peripheral neuropathic pain.
about
The Potential Role of Sensory Testing, Skin Biopsy, and Functional Brain Imaging as Biomarkers in Chronic Pain Clinical Trials: IMMPACT Considerations.Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendationsShort lasting transient effects of a capsaicin 8% patch on nociceptor activation in humans.Usefulness of laser-evoked potentials and quantitative sensory testing in the diagnosis of neuropathic spinal cord injury pain: a multiple case study.Ipsilateral and contralateral sensory changes in healthy subjects after experimentally induced concomitant sensitization and hypoesthesia.Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations.Experimental pain phenotyping in community-dwelling individuals with knee osteoarthritis.Assessment of Chronic Pain: Domains, Methods, and Mechanisms.Exploring pain pathophysiology in patients.[Botulinum toxin A injections in neuropathic pain : A post-hoc subgroup analysis of patients with peripheral nerve injury].High-dose 8% capsaicin patch in treatment of chemotherapy-induced peripheral neuropathy: single-center experience.Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles.Association of serum Ninjurin2 levels with neurologic damage and postherpetic neuralgia occurrence: an observational cohort study in chinese herpeszoster patients.Superiority of capsaicin 8% patch versus oral pregabalin on dynamic mechanical allodynia in patients with peripheral neuropathic pain.Sensory profiling in animal models of neuropathic pain: a call for back-translation.Ephedra Herb extract activates/desensitizes transient receptor potential vanilloid 1 and reduces capsaicin-induced pain.Spatial summation of pain and its meaning to patients.Erythromelalgia: a cutaneous manifestation of neuropathy?Capsaicin 8% patch reversibly reduces A-delta fiber evoked potential amplitudes.
P2860
Q30235485-5D4B5BB1-6129-4BD1-893D-0DF6197B78FBQ30491945-98A6C366-2EA4-4E13-8C1C-FEF2CB37E25DQ35961756-5F354CA1-971C-4498-BE73-4EF0D4EC97B1Q36258457-AED194F8-4B16-4075-BB4C-BA0F0FD57243Q36320939-9639867F-9E13-4F74-B674-36632CE82720Q38827493-A7C94D80-40E7-48E8-9BC9-4E7303B5C19DQ38848882-C3C5B19B-6BF5-4CC2-87D3-ABEF4BCC070CQ38944372-50D8B394-028E-419F-80D1-D2425FAF0723Q38998012-AB6B01DA-7908-475A-8312-4F76925BD952Q39153537-657055A8-2555-4DC3-A43A-725D9DBEFB9DQ41447851-18B00DDF-3C56-4C8D-831A-91060581E557Q42327992-21A3F3C2-2427-4CBA-8A0B-6ADB2C7F3373Q42700933-F4AC3C71-3A97-4E62-96CA-2748E47E6DFCQ47591159-2223EC55-8D93-4A57-98BC-61A9CAE7EB51Q47883719-149D3152-C531-41D3-8E74-2667C7524BDCQ48353623-87AC2E5D-88AA-42BE-8437-3184EA885D4EQ50284051-39F255EF-17B2-4C72-B0F1-D6147E8ABC1DQ52325070-B6E4D9AC-7EF4-4833-B188-7D53623D3094Q54962764-FF60AA79-26CA-454F-82C4-B577B3C18A8D
P2860
Presence of hyperalgesia predicts analgesic efficacy of topically applied capsaicin 8% in patients with peripheral neuropathic pain.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Presence of hyperalgesia predi ...... h peripheral neuropathic pain.
@en
Presence of hyperalgesia predi ...... h peripheral neuropathic pain.
@nl
type
label
Presence of hyperalgesia predi ...... h peripheral neuropathic pain.
@en
Presence of hyperalgesia predi ...... h peripheral neuropathic pain.
@nl
prefLabel
Presence of hyperalgesia predi ...... h peripheral neuropathic pain.
@en
Presence of hyperalgesia predi ...... h peripheral neuropathic pain.
@nl
P2093
P2860
P356
P1476
Presence of hyperalgesia predi ...... th peripheral neuropathic pain
@en
P2093
E K Enax-Krumova
R-D Treede
P2860
P304
P356
10.1002/EJP.703
P577
2015-04-08T00:00:00Z